Issuer directory · Biotechnology · page 6
Biotechnology: issuers 501 to 600 of 832.
Ranked by the amount reported sold on the newest Form D. Page 1 holds the largest raises in the group.
| Issuer | Reported sold | Investors | Exemption | Newest notice | Filings | Platform |
|---|---|---|---|---|---|---|
| SLAM BioTherapeutics, Inc. | $7.7M | 38 | 506(b) | Nov 13, 2023 | 1 | direct |
| Phi Therapeutics, Inc. | $7.7M | 22 | 506(b) | Jun 26, 2024 | 2 | direct |
| Droplet Biosciences, Inc. | $7.6M | 21 | 506(b) | Dec 13, 2023 | 1 | direct |
| Oculogica, Inc. | $7.6M | 24 | 506(b) | May 13, 2024 | 1 | direct |
| Window Therapeutics, Inc. | $7.5M | 10 | 506(b) | Oct 13, 2023 | 1 | direct |
| Avenue Biosciences Holding Inc | $7.4M | 12 | 506(c) | Jan 28, 2026 | 1 | direct |
| Gregor Diagnostics, Inc. | $7.4M | 8 | 506(b) | Dec 16, 2024 | 2 | direct |
| Praesidia Biotherapeutics, Inc. | $7.4M | 52 | 506(b) | Jul 17, 2024 | 3 | direct |
| Saccharo, Inc. | $7.4M | 45 | 506(b) | Sep 8, 2023 | 2 | direct |
| Rebalance Health, Inc. | $7.4M | 39 | 506(b) | Aug 28, 2023 | 1 | direct |
| Zero Point Five Therapeutics, Inc. | $7.2M | 15 | 506(b) | Jul 12, 2023 | 1 | direct |
| EMIT IMAGING, INC. | $7.1M | 17 | 506(b) | Jul 2, 2025 | 2 | direct |
| BRAINBOX SOLUTIONS, INC. | $7.1M | 32 | 506(b) | Nov 7, 2023 | 1 | direct |
| Kytopen Corp. | $7.1M | 13 | 506(b) | Feb 20, 2025 | 1 | direct |
| Amplifyer Bio, Inc. | $7.1M | 12 | 506(b) | Oct 11, 2024 | 1 | direct |
| BiomeSense, Inc. | $7.1M | 27 | 506(b) | Nov 3, 2025 | 1 | direct |
| PharmaCyte Biotech, Inc. | $7.0M | 12 | 506(b) | Sep 4, 2025 | 1 | direct |
| Foldax, Inc. | $7.0M | 10 | 506(b) | Nov 7, 2023 | 1 | direct |
| CIRC Biosciences, Inc. | $7.0M | 19 | 506(b) | May 1, 2024 | 1 | direct |
| VAIL SCIENTIFIC, INC. | $7.0M | 13 | 506(b) | Mar 13, 2025 | 1 | direct |
| OneSkin, Inc. | $7.0M | 11 | 506(b) | Oct 3, 2024 | 1 | direct |
| Circinus Medical Technology LLC | $6.9M | 11 | 506(b) | Feb 9, 2024 | 2 | direct |
| Mel-Mont Medical, Inc. | $6.9M | 69 | 506(b) | Dec 16, 2025 | 2 | direct |
| Valid Inc. | $6.9M | 15 | 506(b) | Jan 22, 2025 | 1 | direct |
| Secretome Therapeutics, Inc. | $6.9M | 48 | 506(b) | Feb 2, 2023 | 1 | direct |
| Bugworks Research, Inc. | $6.8M | 15 | 506(b) | Mar 8, 2024 | 1 | direct |
| Vesalius Longevity Labs (SPV) Inc. | $6.7M | 19 | 506(b) | Mar 19, 2026 | 1 | direct |
| Cellibre, Inc. | $6.7M | 31 | 506(b) | Oct 9, 2024 | 1 | direct |
| Nirrin Technologies, Inc. | $6.7M | 23 | 506(b) | Jun 15, 2026 | 1 | direct |
| Stingray Therapeutics, Inc. | $6.6M | 52 | 506(b) | Dec 28, 2023 | 2 | direct |
| Cytosolix, Inc. | $6.6M | 12 | 506(b) | Jun 28, 2023 | 1 | direct |
| Holobiome, Inc. | $6.6M | 19 | 506(b) | Mar 20, 2024 | 1 | direct |
| CorriXR Therapeutics, Inc. | $6.5M | 4 | 506(b) | Jan 29, 2024 | 2 | direct |
| REGENTIS BIOMATERIALS LTD. | $6.5M | 22 | 506(c) | Jun 25, 2026 | 1 | direct |
| Neurofold Therapeutics Inc. | $6.5M | 18 | 506(b) | Jul 14, 2026 | 1 | direct |
| Paterna BioSciences HoldCo Inc. | $6.3M | 17 | 506(b) | Aug 12, 2026 | 1 | direct |
| Lirum Therapeutics, Inc. | $6.3M | 53 | 506(b) | Feb 23, 2023 | 1 | direct |
| Durin Life Sciences, Inc. | $6.2M | 2 | 506(b) | Jul 21, 2025 | 2 | direct |
| Adze Biotechnology Inc | $6.2M | 21 | 506(c) | Nov 17, 2025 | 4 | direct |
| Kern Australis, LLC | $6.1M | 31 | 506(b) | Jun 18, 2024 | 1 | direct |
| Spinal Simplicity, LLC | $6.1M | 27 | 506(b) | Jul 31, 2025 | 2 | direct |
| Genomenon, Inc. | $6.0M | 30 | 506(b) | Jul 30, 2026 | 1 | direct |
| Biostage, Inc. | $6.0M | 14 | 506(b) | Apr 14, 2023 | 1 | direct |
| AKADEUM LIFE SCIENCES, INC. | $6.0M | 22 | 506(b) | May 30, 2023 | 1 | direct |
| Lytica Therapeutics, Inc. | $6.0M | 17 | 506(b) | Apr 11, 2025 | 1 | direct |
| CryOSA, Inc. | $6.0M | 20 | 506(b) | Aug 1, 2025 | 1 | direct |
| Amplifi Vascular, Inc. | $6.0M | 59 | 506(b) | Jun 30, 2026 | 3 | direct |
| Lapix Therapeutics Inc. | $5.9M | 32 | 506(b) | Apr 27, 2023 | 1 | direct |
| Biomakers, Inc. | $5.9M | 7 | 506(b) | Apr 29, 2026 | 3 | direct |
| TM Holding Companies, Inc. | $5.9M | 78 | 506(b) | Aug 29, 2025 | 1 | direct |
| Linnaeus Therapeutics, Inc. | $5.8M | 12 | 506(b) | Dec 26, 2024 | 2 | direct |
| MIMIVAX INC. | $5.8M | 16 | 506(c) | Jul 12, 2024 | 1 | direct |
| S4 Medical Corp. | $5.8M | 11 | 506(b) | Jul 7, 2023 | 1 | direct |
| Amprion, Inc. | $5.8M | 7 | 506(b) | Sep 27, 2024 | 2 | direct |
| Strella Biotechnology, Inc. | $5.6M | 17 | 506(b) | Sep 10, 2024 | 1 | direct |
| Praeventix, Inc. | $5.6M | 9 | 506(b) | Sep 10, 2026 | 2 | direct |
| Apexigen, Inc. | $5.6M | 13 | 506(b) | Feb 14, 2023 | 1 | direct |
| Bectas Therapeutics, Inc. | $5.5M | 13 | 506(b) | Oct 8, 2025 | 2 | direct |
| GEN1E LIFESCIENCES INC. | $5.5M | 44 | 506(b) | Dec 29, 2025 | 1 | direct |
| AgelessRx, Inc. | $5.5M | 32 | 506(b) | Mar 17, 2026 | 1 | direct |
| Evia Bio, Inc. | $5.5M | 19 | 506(b) | Sep 28, 2026 | 1 | direct |
| Cascade Biocatalysts, Inc. | $5.4M | 41 | 506(b) | Aug 25, 2025 | 1 | direct |
| Oisin Biotechnologies, Inc. | $5.4M | 36 | 506(b) | Jul 12, 2024 | 1 | direct |
| IMAGINOSTICS, INC. | $5.4M | 75 | 506(b) | Apr 6, 2026 | 1 | direct |
| GENE SOLUTIONS LLC | $5.3M | 12 | 506(b) | Jun 3, 2024 | 4 | direct |
| Hilltop Biosciences Inc. | $5.3M | 73 | 506(b) | Mar 31, 2025 | 2 | direct |
| Deep Blue Medical Advances, Inc. | $5.3M | 105 | 506(b) | Sep 22, 2025 | 1 | direct |
| Simbryo Technologies, Inc. | $5.3M | 24 | 506(b) | Jul 27, 2026 | 1 | direct |
| SimBioSys, Inc. | $5.2M | 13 | 506(b) | Jan 6, 2025 | 1 | direct |
| Luminary Therapeutics, Inc. | $5.2M | 49 | 506(b) | Jan 8, 2025 | 3 | direct |
| DesiCorp, Inc. | $5.2M | 15 | 506(b) | Jan 20, 2026 | 3 | direct |
| SyntheX,Inc. | $5.2M | 10 | 506(b) | Jan 11, 2024 | 1 | direct |
| Alphyn Biologics, Inc. | $5.2M | 18 | 506(b) | Apr 15, 2024 | 1 | direct |
| AssayQuant Technologies, Inc. | $5.1M | 21 | 506(c) | Jul 25, 2023 | 2 | direct |
| Qualigen Therapeutics, Inc. | $5.1M | 33 | 506(b) | Nov 22, 2024 | 1 | direct |
| Episteme Prognostics, Inc. | $5.1M | 14 | 506(b) | Sep 4, 2026 | 2 | direct |
| Nanocan Therapeutics Corp | $5.1M | 41 | 506(b) | Feb 18, 2025 | 1 | direct |
| Carterra, Inc. | $5.0M | 15 | 506(b) | Apr 24, 2024 | 1 | direct |
| WaveFront Dynamics Inc. | $5.0M | 17 | 506(b) | Sep 8, 2023 | 1 | direct |
| AutoIVF, Inc. | $5.0M | 24 | 506(b) | May 22, 2025 | 1 | direct |
| Aer Therapeutics, Inc. | $5.0M | 15 | 506(b) | Feb 7, 2025 | 1 | direct |
| SeeLife Impact 5 LLC | $5.0M | 93 | 506(c) | Jan 13, 2026 | 1 | direct |
| SeeLife Impact 6 LLC | $5.0M | 50 | 506(c) | Jan 20, 2026 | 1 | direct |
| SeeLife Impact 4 LLC | $5.0M | 69 | 506(c) | Jan 20, 2026 | 1 | direct |
| SeeLife Impact 3 LLC | $5.0M | 72 | 506(c) | Jan 20, 2026 | 1 | direct |
| SeeLife Impact 2 LLC | $5.0M | 65 | 506(c) | Jan 20, 2026 | 1 | direct |
| SeeLife Impact 1 LLC | $5.0M | 75 | 506(c) | Jan 20, 2026 | 1 | direct |
| C16 Biosciences, Inc. | $5.0M | 17 | 506(b) | Mar 22, 2023 | 1 | direct |
| Solaris Endovascular Inc. | $5.0M | 45 | 506(b) | Oct 1, 2026 | 1 | direct |
| Lazzaro Medical, Inc. | $4.9M | 14 | 506(b) | Jul 22, 2024 | 1 | direct |
| Los Angeles Project Inc | $4.9M | 13 | 506(b) | Jun 8, 2026 | 1 | direct |
| Axelyf, Inc. | $4.8M | 37 | 506(b) | Aug 7, 2025 | 1 | direct |
| Mussel Polymers, Inc. | $4.8M | 51 | 504 | Mar 30, 2026 | 1 | direct |
| EtiraRX, Inc. | $4.8M | 34 | 506(b) | Oct 5, 2023 | 1 | direct |
| Phase Genomics, Inc. | $4.8M | 13 | 506(b) | Mar 21, 2023 | 1 | direct |
| Andson Biotech Inc. | $4.7M | 29 | 506(b) | Oct 22, 2025 | 1 | direct |
| ADIPO THERAPEUTICS, LLC | $4.7M | 20 | 506(b) | Dec 11, 2024 | 1 | direct |
| Innovative Display Systems, LLC | $4.6M | 19 | 506(b) | Feb 3, 2023 | 1 | direct |
| Evecxia, Inc. | $4.6M | 97 | 506(b) | Sep 29, 2025 | 1 | direct |
| Hunterian Medicine LLC | $4.6M | 26 | 506(b) | Sep 25, 2024 | 9 | direct |
